COVTY vs. NVO

Last updated Jun 4, 2026

COVTY (Covestro ADR) and NVO (Novo Nordisk A/S) are both stocks. COVTY operates in Specialty Chemicals (Basic Materials), while NVO operates in Biotechnology (Healthcare). Over the past 5 years, COVTY returned 0.98%/yr vs 2.89%/yr for NVO. At a 0.12 correlation, their price movements are largely independent.

Performance

COVTY vs. NVO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Covestro ADR (COVTY) and Novo Nordisk A/S (NVO). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, COVTY achieves a 2.79% return, which is significantly higher than NVO's -14.57% return.

COVTY

• 1D: 1.16%
• 1M: -0.65%
• YTD: 2.79%
• 6M: 0.63%
• 1Y: 0.89%
• 3Y*: 18.52%
• 5Y*: 0.98%
• 10Y*: —

NVO

• 1D: -2.14%
• 1M: -5.38%
• YTD: -14.57%
• 6M: -8.62%
• 1Y: -38.01%
• 3Y*: -16.72%
• 5Y*: 2.89%
• 10Y*: 6.21%

*Multi-year figures are annualized to reflect compound growth (CAGR)

COVTY vs. NVO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
COVTY Covestro ADR	2.79%	15.75%	-0.88%	50.21%	-31.89%	3.10%	39.29%	-5.98%	-50.89%	54.46%
NVO Novo Nordisk A/S	-14.57%	-39.22%	-15.93%	54.84%	22.66%	63.52%	23.33%	28.70%	-12.98%	52.92%

Correlation

The correlation between COVTY and NVO is -0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.01
Correlation (3Y) Calculated over the trailing 3-year period	0.04
Correlation (5Y) Calculated over the trailing 5-year period	0.08
Correlation (All Time) Calculated using the full available price history since Dec 15, 2016	0.12

The correlation between COVTY and NVO shifts across timeframes, from -0.01 (1 year) to 0.12 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap COVTY : $13.16B NVO : $186.85B
EPS COVTY : -$1.69 NVO : $27.42
PS Ratio COVTY : 1.01 NVO : 0.57
PB Ratio COVTY : 1.88 NVO : 0.92
Total Revenue (TTM) COVTY : $12.91B NVO : $327.80B
Gross Profit (TTM) COVTY : $1.71B NVO : $268.30B
EBITDA (TTM) COVTY : $733.54M NVO : $181.54B

Return for Risk

COVTY vs. NVO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

COVTY

COVTY Risk / Return Rank: 40
COVTY Sharpe Ratio Rank: 43
COVTY Sortino Ratio Rank: 36
COVTY Omega Ratio Rank: 35
COVTY Calmar Ratio Rank: 43
COVTY Martin Ratio Rank: 43

NVO

NVO Risk / Return Rank: 14
NVO Sharpe Ratio Rank: 10
NVO Sortino Ratio Rank: 13
NVO Omega Ratio Rank: 12
NVO Calmar Ratio Rank: 15
NVO Martin Ratio Rank: 19

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

COVTY vs. NVO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Covestro ADR (COVTY) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	COVTY	NVO	Difference
Sharpe ratio Return per unit of total volatility	0.04	-0.74	+0.77
Sortino ratio Return per unit of downside risk	0.21	-0.83	+1.05
Omega ratio Gain probability vs. loss probability	1.03	0.88	+0.15
Calmar ratio Return relative to maximum drawdown	0.09	-0.69	+0.78
Martin ratio Return relative to average drawdown	0.23	-1.03	+1.26
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

COVTY vs. NVO - Sharpe Ratio Comparison

The current COVTY Sharpe Ratio is 0.04, which is higher than the NVO Sharpe Ratio of -0.74. The chart below compares the historical Sharpe Ratios of COVTY and NVO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	COVTY	NVO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.04	-0.74	+0.77
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.03	0.08	-0.04
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.19	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.07	0.47	-0.40

Drawdowns

COVTY vs. NVO - Drawdown Comparison

The maximum COVTY drawdown since its inception was -77.54%, roughly equal to the maximum NVO drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for COVTY and NVO.

Drawdown Indicators

	COVTY	NVO	Difference
Max Drawdown Largest peak-to-trough decline	-77.54%	-74.70%	-2.84%
Max Drawdown (1Y) Largest decline over 1 year	-10.23%	-55.03%	+44.80%
Max Drawdown (3Y) Largest decline over 3 years	-16.19%	-74.70%	+58.51%
Max Drawdown (5Y) Largest decline over 5 years	-57.49%	-74.70%	+17.21%
Max Drawdown (10Y) Largest decline over 10 years	—	-74.70%	—
Current Drawdown Current decline from peak	-33.11%	-69.48%	+36.37%
Average Drawdown Average peak-to-trough decline	-42.07%	-17.76%	-24.31%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.85%	36.88%	-33.03%

Volatility

COVTY vs. NVO - Volatility Comparison

The current volatility for Covestro ADR (COVTY) is 6.36%, while Novo Nordisk A/S (NVO) has a volatility of 7.84%. This indicates that COVTY experiences smaller price fluctuations and is considered to be less risky than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	COVTY	NVO	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.36%	7.84%	-1.48%
Volatility (6M) Calculated over the trailing 6-month period	17.69%	37.83%	-20.14%
Volatility (1Y) Calculated over the trailing 1-year period	23.86%	51.76%	-27.90%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	30.95%	38.21%	-7.26%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	34.38%	32.49%	+1.89%

Dividends

COVTY vs. NVO - Dividend Comparison

COVTY has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 4.29%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
COVTY Covestro ADR	0.00%	0.00%	0.00%	0.00%	9.64%	2.53%	2.23%	4.26%	3.92%	2.44%	0.00%	0.00%
NVO Novo Nordisk A/S	4.29%	3.31%	1.68%	1.00%	1.20%	1.35%	1.87%	2.14%	1.45%	1.52%	2.87%	0.92%

Financials

COVTY vs. NVO - Profitability Comparison

The chart below illustrates the profitability comparison between Covestro ADR and Novo Nordisk A/S over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

COVTY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Covestro ADR reported a gross profit of 210.01M and revenue of 2.89B. Therefore, the gross margin over that period was 7.3%.

NVO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a gross profit of 83.23B and revenue of 96.82B. Therefore, the gross margin over that period was 86.0%.

COVTY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Covestro ADR reported an operating income of -317.00M and revenue of 2.89B, resulting in an operating margin of -11.0%.

NVO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported an operating income of 59.62B and revenue of 96.82B, resulting in an operating margin of 61.6%.

COVTY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Covestro ADR reported a net income of -374.46M and revenue of 2.89B, resulting in a net margin of -13.0%.

NVO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a net income of 48.56B and revenue of 96.82B, resulting in a net margin of 50.2%.

Frequently Asked Questions

Can I hold both COVTY and NVO in my portfolio?

COVTY and NVO have a correlation of -0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, COVTY or NVO?

NVO has higher volatility (7.84%) compared to COVTY (6.36%). In terms of maximum drawdown, COVTY dropped -77.54% vs NVO's -74.70%.

Which has better risk-adjusted returns?

COVTY currently has the higher Sharpe Ratio (0.04 vs -0.74), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.